SECFilingvia Quantisnow

JANX: Janux Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

ByQuantisnow·Oct 1, 2021 · 16:59:36 ET·Wall Street's wire, on your screen.

Stocks in this Quantisnow insightHealth Care

JANXNASDAQJanux Therapeutics Inc.
Alert me

Quantisnow market dataNASDAQ

JANX

Janux Therapeutics Inc.

Market cap
30-day
Sector: Health Care
Industry: Biotechnology: Pharmaceutical Preparations
Listed since: 2021

Get push alerts for JANX

Follow JANX and get a push notification the moment its next story breaks.

Full JANX profile on Quantisnow

Delivered by Quantisnow

Get the next JANX story the moment it breaks

Quantisnow reads SEC filings, FDA decisions, analyst ratings, insider trades and press releases straight off the wire and alerts you on the tickers you follow, so you read it before the market prices it in.

Push to your phoneQuantisnow app for iOS and Android
Email alertHeadline, tickers and the source link
Live feedStreams in as the wire publishes

Quantisnow Free vs Plus
Feature	Free	Plus
Delivery	On a delay	Real time, ~350ms
Followed tickers	Up to 5	Up to 250
Push + email alerts	Daily limit	Every story
Price	$0	$69/mo

Continue with Google Sign up with email Free to start. Plus is $69/mo

Original source Picked up and delivered by Quantisnow in real time